David A. Armstrong

David A. Armstrong

Auto-generated profile, based on publicly available information

David A. Armstrong

Dartmouth Health

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
CLCorina Lesseur
Corina Lesseur
DADavid A. Armstrong
David A. Armstrong
APAlison G. Paquette
Alison G. Paquette
ZLZhigang Li
Zhigang Li
JPJames F. Padbury
James F. Padbury
CMCarmen J. Marsit
Carmen J. Marsit

8 December 2017 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
SCSabrina Ceeraz
Sabrina Ceeraz
SESusan K. Eszterhas
Susan K. Eszterhas
PSPetra A. Sergent
Petra A. Sergent
DADavid A. Armstrong
David A. Armstrong
AAAlix Ashare
Alix Ashare
RFRoy A. Fava
Roy A. Fava
In addition to activated T cells, the immune checkpoint inhibitor “V domain-containing Ig suppressor of T-cell activation” (VISTA) is expressed by myeloid cell types, including macrophages and neutrophils. The importance of VISTA expression by myeloid cells to antibody-induced arthritis and its potential for relevance in human disease was evaluated. VISTA was immunolocalized in normal and arthritic human synovial tissue sections and synovial tissue lysates were subjected to western blot analysis. The collagen antibody-induced arthritis model (CAIA) was performed with DBA/1 J mice treated with antibodies against VISTA and with VISTA-deficient mice (V-KO). Total mRNA from arthritic joints, spleens, and cultured macrophages was analyzed with NanoString arrays. Cytokines secreted by splenic inflammatory macrophages were determined. In-vitro chemotaxis and signal transduction assays were performed with cultured macrophages. VISTA protein was localized to synovial membrane cells, neutrophils, and scattered cells in lymphocyte-rich foci and was detected by western blot analysis in normal synovium and synovium from rheumatoid arthritis patients. Deficiency of VISTA or treatment of mice with anti-VISTA monoclonal antibodies attenuated CAIA. Joint damage and MMP-3 expression were significantly reduced in V-KO mice. Surface expression of C5a receptor was reduced on monocytes, neutrophils, and cultured macrophages from V-KO. Upon Fc receptor engagement in vitro, gene expression by V-KO macrophages was altered profoundly compared to WT, including a significant induction of IL-1 receptor antagonist (IL1rn). VISTA expression supports immune-complex inflammation in CAIA and VISTA is expressed in human synovium. VISTA supports optimal responses to C5a and modulates macrophage responses to immune complexes.

1 February 2014 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
CLCorina Lesseur
Corina Lesseur
DADavid A. Armstrong
David A. Armstrong
MMMegan A. Murphy
Megan A. Murphy
AAAllison A. Appleton
Allison A. Appleton
DKDevin C Koestler
Devin C Koestler
CMCarmen J. Marsit
Carmen J. Marsit

30 May 2017 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
DADavid A. Armstrong
David A. Armstrong
ANAmanda B. Nymon
Amanda B. Nymon
CRCarol S. Ringelberg
Carol S. Ringelberg
CLCorina Lesseur
Corina Lesseur
HHHaley F. Hazlett
Haley F. Hazlett
AAAlix Ashare
Alix Ashare
Numerous pulmonary diseases manifest with upper lobe predominance including cystic fibrosis, smoking-related chronic obstructive pulmonary disease, and tuberculosis. Zonal hypoxia, characteristic of these pulmonary maladies, and oxygen stress in general is known to exert profound effects on various important aspects of cell biology. Lung macrophages are major participants in the pulmonary innate immune response and regional differences in macrophage responsiveness to hypoxia may contribute in the development of lung disease. MicroRNAs are ubiquitous regulators of human biology and emerging evidence indicates altered microRNA expression modulates respiratory disease processes. The objective of this study is to gain insight into the epigenetic and cellular mechanisms influencing regional differences in lung disease by investigating effect of hypoxia on regional microRNA expression in the lung. All studies were performed using primary alveolar macrophages (n = 10) or bronchoalveolar lavage fluid (n = 16) isolated from human subjects. MicroRNA was assayed via the NanoString nCounter microRNA assay. Divergent molecular patterns of microRNA expression were observed in alternate lung lobes, specifically noted was disparate expression of miR-93 and miR-4454 in alveolar macrophages along with altered expression of miR-451a and miR-663a in bronchoalveolar lavage fluid. Gene ontology was used to identify potential downstream targets of divergent microRNAs. Targets include cytokines and matrix metalloproteinases, molecules that could have a significant impact on pulmonary inflammation and fibrosis. Our findings show variant regional microRNA expression associated with hypoxia in alveolar macrophages and BAL fluid in the lung—upper vs lower lobe. Future studies should address whether these specific microRNAs may act intracellularly, in a paracrine/endocrine manner to direct the innate immune response or may ultimately be involved in pulmonary host-to-pathogen trans-kingdom cross-talk.

1 August 2020 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
DADavid A Armstrong
David A Armstrong
MLMin Kyung Lee
Min Kyung Lee
HHHaley F. Hazlett
Haley F. Hazlett
JDJohn A Dessaint
John A Dessaint
DMDiane L. Mellinger
Diane L. Mellinger
AAAlix Ashare
Alix Ashare
Pseudomonas aeruginosa, a Gram-negative bacterium, is one of the most common pathogens colonizing the lungs of cystic fibrosis patients. P. aeruginosa secrete extracellular vesicles (EVs) that contain LPS and other virulence factors that modulate the host’s innate immune response, leading to an increased local proinflammatory response and reduced pathogen clearance, resulting in chronic infection and ultimately poor patient outcomes. Lung macrophages are the first line of defense in the airway innate immune response to pathogens. Proper host response to bacterial infection requires communication between APC and T cells, ultimately leading to pathogen clearance. In this study, we investigate whether EVs secreted from P. aeruginosa alter MHC Ag expression in lung macrophages, thereby potentially contributing to decreased pathogen clearance. Primary lung macrophages from human subjects were collected via bronchoalveolar lavage and exposed to EVs isolated from P. aeruginosa in vitro. Gene expression was measured with the NanoString nCounter gene expression assay. DNA methylation was measured with the EPIC array platform to assess changes in methylation. P. aeruginosa EVs suppress the expression of 11 different MHC-associated molecules in lung macrophages. Additionally, we show reduced DNA methylation in a regulatory region of gene complement factor B (CFB) as the possible driving mechanism of widespread MHC gene suppression. Our results demonstrate MHC molecule downregulation by P. aeruginosa–derived EVs in lung macrophages, which is consistent with an immune evasion strategy employed by a prokaryote in a host–pathogen interaction, potentially leading to decreased pulmonary bacterial clearance.

10 December 2018 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
YCYoudinghuan Chen
Youdinghuan Chen
DADavid A. Armstrong
David A. Armstrong
LSLucas A Salas
Lucas A Salas
HHHaley F. Hazlett
Haley F. Hazlett
ANAmanda B. Nymon
Amanda B. Nymon
AAAlix Ashare
Alix Ashare
Lung macrophages are major participants in the pulmonary innate immune response. In the cystic fibrosis (CF) lung, the inability of lung macrophages to successfully regulate the exaggerated inflammatory response suggests dysfunctional innate immune cell function. In this study, we aim to gain insight into innate immune cell dysfunction in CF by investigating alterations in DNA methylation in bronchoalveolar lavage (BAL) cells, composed primarily of lung macrophages of CF subjects compared with healthy controls. All analyses were performed using primary alveolar macrophages from human subjects collected via bronchoalveolar lavage. Epigenome-wide DNA methylation was examined via Illumina MethylationEPIC (850 K) array. Targeted next-generation bisulfite sequencing was used to validate selected differentially methylated CpGs. Methylation-based sample classification was performed using the recursively partitioned mixture model (RPMM) and was tested against sample case-control status. Differentially methylated loci were identified by fitting linear models with adjustment of age, sex, estimated cell type proportions, and repeat measurement. RPMM class membership was significantly associated with the CF disease status (P = 0.026). One hundred nine CpG loci were differentially methylated in CF BAL cells (all FDR ≤ 0.1). The majority of differentially methylated loci in CF were hypo-methylated and found within non-promoter CpG islands as well as in putative enhancer regions and DNase hyper-sensitive regions. These results support a hypothesis that epigenetic changes, specifically DNA methylation at a multitude of gene loci in lung macrophages, may participate, at least in part, in driving dysfunctional innate immune cells in the CF lung.